Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study to Assess OPB-31121 in Advanced Leukemias or Myelodysplastic Syndromes

This study has been terminated.
(Colloborator-Sponsor decision to terminate.)
Otsuka Pharmaceutical Co., Ltd.
Information provided by (Responsible Party):
M.D. Anderson Cancer Center Identifier:
First received: December 8, 2009
Last updated: July 19, 2012
Last verified: July 2012
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: August 2011
  Primary Completion Date: August 2011 (Final data collection date for primary outcome measure)